FindTrial
Sign In

Tele-yoga for prevention and management of COVID-19

Tele-yoga as an adjunct intervention for management of mild to moderate cases of COVID-19:a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027915
Enrollment
230
Registered
2020-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: J708- Respiratory conditions due to other specified external agents

Interventions

Intervention1: Tele-yoga: Integrated yoga intervention of 30 minutes with 10 minutes of pranayama, twice a day. Control Intervention1: NIL: NIL

Sponsors

AYUSH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with mild or moderate COVID-19 based on clinical symtoms of fever, respiratory and other symptoms, and /or the manifestation of pneumonia as confirmed by radiographic imaging. Severe patients who meet the definition of severe pneumonia (Shortness of breath,RR�30 bpm;In a resting state:SPO2�93%;PaO2/FiO2�300mmHg) Patients with comorbities of Type 2 Diabetes and/or hypertension Willing to participate in this study, willing to participate in regular follow-up during the study.

Exclusion criteria

Exclusion criteria: Prior experience of yoga Breastfeeding and pregnant patients were excluded based on their declaration and pregnancy test results when required. Patients diagnosed with severe or critical COVID-19: respiratory failure, septic shock, and/or multiple organ dysfunction (MOD) or failure (MOF).

Design outcomes

Primary

MeasureTime frame
Clinical improvement through odds ratio of 7 point ordinal scaleTimepoint: Time frame of 15 days followed by follow up of 1 month—

Secondary

MeasureTime frame
Clinical Severity (Oxygenation, Mechanical Ventilation), duration of hospitalization (days), Mortality and safety as compared to the standard of care Clinical assessments will include the routine test performed at the hospital for complete blood count, creatinine levels, blood electrolytes (including kaliemia), prothrombin time and international normalized ratio (INR), glucose, total bilirubin, ALT, and ASTTimepoint: Time frame of 15 days followed by follow up of 1 month—

Countries

India

Contacts

Public ContactDr Manjunath NK

SVYASA Yoga University

nkmsharma@svyasa.org

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026